OBX（OBX）價格預測OBXOBX

Galera Therapeutics Inc is not a good buy right now due to its significant recent decline and negative financial metrics. The stock has dropped 18.09% in the last five days and 34.80% year-to-date. Additionally, the price-to-earnings ratio is -12.68, indicating negative earnings, which raises concerns about profitability. Although analysts have positive ratings, the lack of a concrete price target from TD Cowen and the substantial drop in price suggest caution.

(OBX) last closed at $16.82, losing -1.58%. These facts feed the 1-day and 1-week OBX price prediction above.